Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,622 public trials 831 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Completed

Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma

NCT00036140

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Research Center Los Angeles, California, United States
  • Research Center Los Angeles, California, United States
  • Research Center Rancho Mirage, California, United States
  • Research Center Cleveland, Ohio, United States
View Trial Details
Completed

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

NCT00002386

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood-Borne Infections, +22 more
Locations
  • USCF San Francisco, California, United States
  • Georgetown U Med Ctr / Div of Hematology / Oncology Washington D.C., District of Columbia, United States
  • Emory Univ Atlanta, Georgia, United States
  • Riley Hosp for Children Indianapolis, Indiana, United States
View Trial Details
Terminated

Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX

NCT04628871

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Carbohydrate Metabolism, Inborn Errors, +24 more
Locations
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • New York University Grossman School of Medicine New York, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details
Terminated

BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma

NCT05376345

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Beijing Boren Hospital Beijing, Beijing Municipality, China
  • Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China
  • Shanghai Changzheng Hospital Shanghai, China
  • Shanghai Fourth People's Hospital Affiliated to Tongji University Shanghai, China
View Trial Details
Suspended

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

NCT06179888

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 74 locations
View Trial Details

Related conditions